We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+8.44%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$1.48B
AUM Growth
+$175M
Cap. Flow
+$59.5M
Cap. Flow %
4.02%
Top 10 Hldgs %
38.11%
Holding
211
New
41
Increased
36
Reduced
32
Closed
77

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$10.3M
2
IOVA icon
Iovance Biotherapeutics
IOVA
+$9.84M
3
HOWL icon
Werewolf Therapeutics
HOWL
+$9.68M
4
ALT icon
Altimmune
ALT
+$9.34M
5
TWLO icon
Twilio
TWLO
+$9.2M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$49.7M
2
ABBV icon
AbbVie
ABBV
+$26.3M
3
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$12.9M
4
BMY icon
Bristol-Myers Squibb
BMY
+$12.6M
5
PANW icon
Palo Alto Networks
PANW
+$10.4M

Sector Composition

Rank Sector Weight
1 Healthcare 55.47%
2 Technology 8.46%
3 Industrials 4.82%
4 Financials 2.07%
5 Consumer Discretionary 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNCE
176
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
– –
-12,200
Closed -$2.47M
LCAHU
177
DELISTED
Landcadia Holdings IV, Inc. Units
LCAHU
– –
-150,000
Closed -$1.49M
NSTB
178
DELISTED
Northern Star Investment Corp. II
NSTB
– –
-155,367
Closed -$1.55M
FTCH
179
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
– –
-80,000
Closed -$4.24M
SUNL
180
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
– –
-2,500
Closed -$523K
KDNY
181
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-101,666
Closed -$1.58M
BGRY
182
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
– –
-109,994
Closed -$1.11M
FMIVU
183
DELISTED
Forum Merger IV Corporation Unit
FMIVU
– –
-150,000
Closed -$1.49M
CYXT
184
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
– –
-170,937
Closed -$1.7M
FNCH
185
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
– –
-5,000
Closed -$2.39M
LABP
186
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
– –
-7,000
Closed -$674K
VPCBU
187
DELISTED
VPC Impact Acquisition Holdings II Unit
VPCBU
– –
-100,000
Closed -$986K
AGGRU
188
DELISTED
Agile Growth Corp Units
AGGRU
– –
-50,000
Closed -$496K
LOKM.U
189
DELISTED
Live Oak Mobility Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-fifth of one warrant
LOKM.U
– –
-75,000
Closed -$749K
FTEV.U
190
DELISTED
FinTech Evolution Acquisition Group Units, each consisting of one Class A Ordinary Share, and one-third of one redeemable warrant
FTEV.U
– –
-25,000
Closed -$247K
MDH.U
191
DELISTED
MDH Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one redeemable warrant
MDH.U
– –
-31,000
Closed -$308K
GLHAU
192
DELISTED
Glass Houses Acquisition Corp. Unit
GLHAU
– –
-89,884
Closed -$902K
LGV.U
193
DELISTED
Longview Acquisition Corp. II Units, each consisting of one share of Class A Common Stock and one-fifth of one redeemable Warrant
LGV.U
– –
-300,000
Closed -$3.01M
VTIQU
194
DELISTED
VectoIQ Acquisition Corp. II Unit
VTIQU
– –
-50,000
Closed -$507K
ZWRKU
195
DELISTED
Z-Work Acquisition Corp. Units
ZWRKU
– –
-50,000
Closed -$498K
RADA
196
DELISTED
Rada Electronic Industries Ltd
RADA
– –
-407,925
Closed -$4.9M
PHAS
197
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
– –
-750,000
Closed -$2.6M
EJFAU
198
DELISTED
EJF Acquisition Corp. Unit
EJFAU
– –
-49,900
Closed -$497K
VPCC.U
199
DELISTED
VPC Impact Acquisition Holdings III, Inc. Units, each consisting of one share of Class A common stoc
VPCC.U
– –
-100,000
Closed -$987K
MACQU
200
DELISTED
MCAP Acquisition Corporation Unit
MACQU
– –
-100,000
Closed -$995K
5 6 7
8
9

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q2 2021 Portfolio in Review

As of Q2 2021, Sphera Funds Management held 211 positions worth $1.48B, up 13% from $1.3B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Sphera Funds Management deployed $59.5M of net new capital in Q2 2021, opening 41 new positions and adding to 36 existing holdings. Its largest new stake was Iovance Biotherapeutics: 378,642 shares worth $9.85M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 63% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Eli Lilly, an estimated $49.7M trimmed.

  • Sphera Funds Management's largest Q2 2021 buy was Iovance Biotherapeutics: 378,642 shares worth $9.85M.
  • Sphera Funds Management added most to AstraZeneca in Q2 2021, an estimated $10.3M increase.
  • Sphera Funds Management's biggest Q2 2021 reduction was Eli Lilly, cutting an estimated $49.7M.
  • Sphera Funds Management fully exited Bristol-Myers Squibb in Q2 2021, selling an estimated $12.6M.
  • Sphera Funds Management's ten largest holdings make up 38% of its $1.48B portfolio in Q2 2021.
  • Sphera Funds Management opened 41 new positions and closed 77 in Q2 2021.
  • Sphera Funds Management's portfolio value rose 13% quarter-over-quarter to $1.48B.

Based on Sphera Funds Management's 13F filing for Q2 2021, filed 17 Aug 2021.